Publication & Citation Trends
Publications
0 total
The role of polygenic risk and susceptibility genes in breast cancer over the course of life OA
Cited by 122
Semantic Scholar
Evaluation of the effect of UGT1A1 polymorphisms on the pharmacokinetics of oral and long-acting injectable cabotegravir OA
Cited by 11
Semantic Scholar
Comparing low-pass sequencing and genotyping for trait mapping in pharmacogenetics OA
Cited by 39
Semantic Scholar
552. Evaluation of Relationships Between UGT1A1 Genotypes and Cabotegravir Long-Acting Injection Pharmacokinetics Among HIV-Infected Subjects in the LATTE-2 Study OA
Cited by 0
Semantic Scholar
Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib OA
Cited by 18
Semantic Scholar
Assessing the feasibility of GSK’s clinical genetic data re-use for drug target identification and validation: A respiratory case study OA
Cited by 0
Semantic Scholar
Pyrexia in dabrafenib-treated melanoma patients is not associated with common genetic variation or HLA polymorphisms.
Cited by 7
Semantic Scholar
BRCA1/2 mutations associated with progression-free survival in ovarian cancer patients in the AGO-OVAR 16 study.
Cited by 47
Semantic Scholar
Research Topics
Genetic Associations and Epidemiology
(3)
Lung Cancer Treatments and Mutations
(2)
HER2/EGFR in Cancer Research
(2)
BRCA gene mutations in cancer
(2)
Cancer Genomics and Diagnostics
(2)
Affiliations
Novartis (Switzerland)
GlaxoSmithKline (United Kingdom)
Sanofi (France)
GlaxoSmithKline (United States)
PAREXEL International (United States)